Pharma News

Crack GPAT — Prepare for GPAT Online 

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Lupin Unveils Strategic Partnership Program to Expand Reach of its Long-Acting Injectable Platform
    9 October 2025

    Lupin Unveils Strategic Partnership Program to Expand Reach of its Long-Acting Injectable Platform

    PrecisionSphere™ demonstrates efficacy and safety in drug delivery and is ready for commercial use, following the recent United States Food and Drug Administration’s (U.S. FDA) approval for the first product developed with this platform.
  • 9 October 2025
    Programmable proteins use logic to improve targeted drug delivery
    Targeted drug delivery is a powerful and promising area of medicine. Therapies that pinpoint the exact areas of the body where they’re needed and nowhere they’re not can reduce the medicine dosage and avoid potentially harmful “off target” effects elsewhere in the body.
  • 9 October 2025
    Protein nanorings designed to detect and neutralise SARS-CoV2 virus
    An international team of scientists has generated a new ring-shaped protein nanomaterial capable of strongly binding to and neutralising the SARS-CoV2 virus.
  • 8 October 2025
    International Webinar Series by Saveetha College of Pharmacy

    Saveetha College of Pharmacy, Saveetha Institute of Medical and Technical Sciences (SIMATS) Chennai, Tamil Nadu, India; jointly in association with the Indian Pharmaceutical Association (IPA) organized an International Webinar Series 2025, on the theme "Advancing Pharmacy Practice: Bridging Healthcare Access and Patient Support," held during September 22 - 24, 2025.

  • 7 October 2025
    New drug combination offers hope for men with advanced prostate cancer
    A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with specific genetic mutations, finds a major international trial led by UCL researchers.
  • 7 October 2025
    New discovery finds gene converts insulin-producing cells into blood-sugar boosters
    Scientists at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the U.S., and a leading research center for diabetes and other life-threatening illnesses, have uncovered a gene called SMOC1 that plays a surprising role in the development of type 2 diabetes (T2D) by converting pancreatic cells that normally produce insulin into those that increase blood sugar.
  • 7 October 2025
    Tiny Particles and Vinegar May Help Kill Superbugs, Say Scientists
    A new study has found that a simple kitchen ingredient — vinegar — can become a powerful germ killer when mixed with special microscopic particles. Scientists have discovered that this new combination could help fight dangerous bacteria that no longer respond to regular antibiotics.
  • 7 October 2025
    Eli Lilly announces USD 1 Billion investment in India
    Global pharmaceutical giant Eli Lilly and Company has announced plans to invest over USD 1 billion in India to expand its manufacturing capabilities and strengthen its presence in one of the world’s fastest-growing healthcare markets.
  • 7 October 2025
    Wockhardt Submits New Drug Application to USFDA for Zidebactam-Cefepime
    Wockhardt announced the submission of New Drug Application (NDA) to the U.S. Food and Drug Administration (US FDA) for its novel antibacterial agent Zidebactam-Cefepime injection
  • 1 October 2025
    AbbVie expands Biologics Manufacturing and R&D Presence in the U.S., invests USD 70 mn

    AbbVie announced the start of construction of a USD 70 million expansion at its AbbVie Bioresearch Center (ABC) in Worcester, Mass., which serves as a center of excellence for biologics research and development and manufacturing. This expansion is part of the company's previously announced commitment to invest more than USD 10 billion of capital in the U.S. to broadly support innovation and expand critical biologics manufacturing capabilities and capacity.

Subscribe to Pharma News